本文選題：食管癌　切入點(diǎn)：吻合口瘺　出處：《吉林大學(xué)》2017年碩士論文

【摘要】：研究目的:結(jié)合文獻(xiàn),綜合分析食管癌根治術(shù)后影響胸內(nèi)吻合口瘺發(fā)生的主要相關(guān)因素。探究“改良式食管-管狀胃吻合”與“環(huán)式套入包埋”聯(lián)合應(yīng)用的手術(shù)技巧對(duì)于預(yù)防胸內(nèi)吻合口瘺發(fā)生是否有積極的作用。研究方法:采用具有前瞻性的隨機(jī)對(duì)照試驗(yàn)方式,納入我院胸外科自2014年11月至2016年11月行Sweet術(shù)式的胸中下段食管癌鱗癌患者共200例。將所有入選患者隨機(jī)分為對(duì)照組和試驗(yàn)組兩個(gè)組別:對(duì)照組于管狀胃切割閉合線近側(cè)端下方平行于長(zhǎng)軸切開管狀胃,置入吻合器行食管-管狀胃端側(cè)吻合,對(duì)吻合環(huán)行漿肌層多點(diǎn)式加強(qiáng)縫合,常規(guī)閉合胃壁造口,對(duì)造口全層包埋縫合,100例,男92例,女8例;試驗(yàn)組于管狀胃頂端垂直于管胃長(zhǎng)軸另造口,置入吻合器,反折管狀胃胃底與食管殘端行端側(cè)吻合,切割閉合器閉合并切除管狀胃頂端造口及周圍胃壁,全層包埋縫合后,將管狀胃輕輕上提套住吻合口,使胃壁折疊約2-3cm,在胃壁折疊的最高點(diǎn)與食管下段行環(huán)式漿肌層包埋縫合加固,100例,男94例,女6例。兩組患者術(shù)中均預(yù)置食管床引流管;術(shù)后均給予早期腸內(nèi)營(yíng)養(yǎng)。兩組患者自術(shù)后第4天至第7天每日均給予口服亞甲藍(lán)檢測(cè),凡有一次出現(xiàn)胸引管或縱隔引流管藍(lán)染的,判定為發(fā)生吻合口瘺;對(duì)于兩組中行4次亞甲藍(lán)試驗(yàn)均陰性的患者,于拔除引流管前再行亞甲藍(lán)試驗(yàn)一次,5次亞甲藍(lán)試驗(yàn)均為陰性者,判定未發(fā)生吻合口瘺。主要對(duì)發(fā)生術(shù)后胸內(nèi)吻合口瘺的患者的組別、人數(shù)、性別、病理分期進(jìn)行記錄和對(duì)比分析。病理分期參照食管癌TNM國(guó)際分期第7版。采用SPSS 21.0統(tǒng)計(jì)軟件對(duì)各項(xiàng)數(shù)據(jù)進(jìn)行分析,以α=0.05為檢驗(yàn)標(biāo)準(zhǔn),P0.05表示差異有統(tǒng)計(jì)學(xué)意義。結(jié)果:兩組患者一般狀況相當(dāng)(P0.05),無統(tǒng)計(jì)學(xué)差異,有可比性。同等條件下性別不同對(duì)術(shù)后胸內(nèi)吻合口瘺的發(fā)生沒有統(tǒng)計(jì)學(xué)差異(P0.05)。試驗(yàn)組對(duì)吻合和包埋的改進(jìn),能明顯降低術(shù)后胸內(nèi)吻合口瘺的發(fā)生率,與對(duì)照組的差別有統(tǒng)計(jì)學(xué)意義(P0.05)。同等條件下,病理分期對(duì)吻合口瘺的發(fā)生率有影響,分期越晚,瘺發(fā)生率越高,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。研究結(jié)論:本研究所采用的“改良式食管-管狀胃吻合”和對(duì)吻合口的“環(huán)式套入包埋”,能有效預(yù)防Sweet術(shù)式食管癌根治術(shù)術(shù)后胸內(nèi)吻合口瘺的發(fā)生,與術(shù)中預(yù)置的食管床引流管,共同構(gòu)成了對(duì)于Sweet術(shù)后胸內(nèi)吻合口瘺的三位一體式的預(yù)防措施,改善了吻合口血供,降低了吻合口的張力,為吻合口營(yíng)造了良好的局部愈合環(huán)境,措施全面,技巧簡(jiǎn)單,效果顯著,應(yīng)予推廣。
[Abstract]:Objective: to combine the literature, The main factors related to the occurrence of intrathoracic anastomotic fistula after radical resection of esophageal cancer were analyzed. The combined application of "modified esophagojejunostomy" and "ring embedding" was explored to prevent intrathoracic anastomosis. Whether oral fistula has a positive effect. Methods: a prospective randomized controlled trial was used. From November 2014 to November 2016, 200 patients with squamous cell carcinoma of middle and lower thoracic esophageal carcinoma underwent Sweet operation in our hospital. All the patients were randomly divided into two groups: the control group and the experimental group. The proximal end of the closure line is parallel to the long axis incision of the tube stomach. The esophagojejunostomy was performed with stapler. The anastomosed circular serous myometrium was sutured with multiple points, and the gastric wall was routinely closed. 100 cases (92 males and 8 females) were buried and sutured in the whole layer of anastomosis. In the test group, the tip of the tube stomach was perpendicular to the long axis of the tube stomach, and a stapler was inserted. The stomach fundus of the tube was anastomosed with the esophageal stump by end-to-side anastomosis. The cut-closure device closed and removed the orifice of the top of the tube stomach and the surrounding gastric wall. After the whole layer was buried and sutured, The tubular stomach was gently lifted up to cover the anastomotic site, and the gastric wall was folded about 2-3 cm. 100 cases (94 males and 6 females) were strengthened with circular sarcoplasmic muscular layer embedding at the highest point of gastric wall folding and the subesophagus segment. All patients in both groups were preplaced with esophageal bed drainage tube during the operation. The patients in both groups were given oral methylene blue test from the 4th to 7th day after operation. If there was a blue staining of the thoracic drainage tube or the mediastinal drainage tube, the anastomotic leakage was determined. For the two groups of patients who were negative for 4 methylene blue tests, one methylene blue test and five methylene blue tests were all negative before the drainage tube was removed. The group, number and sex of patients with intrathoracic anastomotic fistula after operation were determined. The pathological stages were recorded and compared with each other. The pathological staging was based on the seventh edition of TNM international staging of esophageal carcinoma. The data were analyzed by SPSS 21.0 software. Results: the general condition of the two groups was similar to that of P0.05, and there was no statistical difference between the two groups. There was no significant difference in the incidence of intrathoracic anastomotic leakage between the two groups under the same conditions. The improvement of anastomosis and embedding in the trial group could significantly reduce the incidence of postoperative intrathoracic anastomotic leakage. Under the same conditions, pathological staging had an effect on the incidence of anastomotic leakage, and the later the stage was, the higher the incidence of fistula was. The difference was statistically significant (P 0.05). Conclusion: the modified esophagojejunostomy and the loop embedding of anastomosis can effectively prevent the occurrence of intrathoracic anastomotic leakage after radical resection of esophageal carcinoma by Sweet. Together with the pre-inserted esophageal bed drainage tube during the operation, the three-in-one preventive measures for intrathoracic anastomotic leakage after Sweet were formed, which improved the blood supply of the anastomotic site, reduced the tension of the anastomotic site, and created a good local healing environment for the anastomotic site. The measure is comprehensive, the skill is simple, the effect is remarkable, should be popularized.
【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R735.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王明霞,劉桂芝;食管癌術(shù)后胸內(nèi)吻合口瘺的護(hù)理[J];齊魯護(hù)理雜志;2003年09期

2 趙慧杰,徐霞;食管癌術(shù)后胸內(nèi)吻合口瘺的觀察及護(hù)理[J];河南大學(xué)學(xué)報(bào)(醫(yī)學(xué)科學(xué)版);2004年01期

3 蒲麗華;食管(賁門)癌術(shù)后胸內(nèi)吻合口瘺再手術(shù)的護(hù)理[J];現(xiàn)代醫(yī)藥衛(wèi)生;2005年09期

4 韓靜;張梅;陳路路;劉輝;王福紅;陳緒霞;;食管癌術(shù)后胸內(nèi)吻合口瘺再次手術(shù)1例護(hù)理體會(huì)[J];齊魯護(hù)理雜志;2006年04期

5 繆巧英;劉學(xué)英;張艷華;;7例食管癌術(shù)后并發(fā)胸內(nèi)吻合口瘺原因分析及護(hù)理[J];天津護(hù)理;2008年03期

6 胡新春;;食管癌術(shù)后合并胸內(nèi)吻合口瘺的觀察與護(hù)理[J];護(hù)理研究;2009年30期

7 潘鉆琴;;食管癌術(shù)后并發(fā)胸內(nèi)吻合口瘺的臨床觀察和護(hù)理體會(huì)[J];實(shí)用臨床醫(yī)藥雜志;2011年16期

8 吳應(yīng)虎;夏平;王道軍;紀(jì)培軍;;吻合胸內(nèi)吻合口瘺7例治療分析[J];中國(guó)誤診學(xué)雜志;2011年34期

9 劉靜;;食管癌術(shù)后并發(fā)胸內(nèi)吻合口瘺的觀察與護(hù)理[J];中國(guó)醫(yī)學(xué)創(chuàng)新;2011年22期

10 王崇云;;治療食管癌和賁門癌術(shù)后胸內(nèi)吻合口瘺的體會(huì)[J];川北醫(yī)學(xué)院學(xué)報(bào);1986年02期

相關(guān)會(huì)議論文 前4條

1 孫愛英;周秀芳;;食管癌術(shù)后并發(fā)胸內(nèi)吻合口瘺的護(hù)理[A];2012年“河南省腫瘤�？谱o(hù)士職業(yè)安全防護(hù)及新技術(shù)交流”學(xué)術(shù)會(huì)議論文集[C];2012年

2 劉輝;周秀芳;孫愛英;;食管癌術(shù)后并發(fā)胸內(nèi)吻合口瘺的護(hù)理[A];2012年河南省外科創(chuàng)傷及災(zāi)難救治�？浦R(shí)學(xué)術(shù)會(huì)議論文集[C];2012年

3 趙云;孟愛鳳;馬圣香;曠玉明;張偉;徐菁莉;;鼻胃管經(jīng)瘺口引流治療食管癌術(shù)后胸內(nèi)吻合口瘺患者的護(hù)理[A];中華護(hù)理學(xué)會(huì)全國(guó)腫瘤護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2010年

4 周志有;夏銀獻(xiàn);施亞明;陳獻(xiàn)國(guó);唐志苗;;食管癌和賁門癌術(shù)后胸內(nèi)吻合口瘺的臨床分析[A];2009年浙江省胸心外科學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2009年

相關(guān)碩士學(xué)位論文 前2條

1 李孟飛;改良吻合及包埋方式預(yù)防食管癌Sweet術(shù)式胸內(nèi)吻合口瘺的經(jīng)驗(yàn)總結(jié)[D];吉林大學(xué);2017年

2 金新天;食管、賁門癌術(shù)后胸內(nèi)吻合口瘺診斷與治療[D];吉林大學(xué);2007年

，

本文編號(hào)：1652955